Schedule II - Valuation and Qualifying Accounts

12 Months Ended

Jan. 01, 2022

Notes to Financial Statements

SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]

USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES

SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS

(in thousands)

Description	Balance at beginning of period		Charged to costs and expenses		Deductions		Balance at end of period
January 1, 2022
Allowance for sales returns	$	819	$	7,213	$	7,485	$	547
Allowance for doubtful accounts	$	372	$	148	$	16	$	504
Valuation allowance - deferred tax assets	$	81,401	$	18,557	$	-	$	99,958
January 2, 2021
Allowance for sales returns	$	772	$	115	$	68	$	819
Allowance for doubtful accounts	$	261	$	131	$	20	$	372
Valuation allowance - deferred tax assets	$	64,285	$	17,116	$	-	$	81,401
December 28, 2019
Allowance for sales returns	$	839	$	168	$	235	$	772
Allowance for doubtful accounts	$	139	$	146	$	24	$	261
Valuation allowance - deferred tax assets	$	44,199	$	20,086	$	-	$	64,285